Business
Ocumetics Webinar - Discussion of One-Month Postoperative Patient Results
(TheNewswire) Calgary, Alberta – TheNewswire - October 14, 2025 - Ocumet...
About this update from Ocumetics Technology Corp
[{"type":"text","content":"Ocumetics Webinar - Discussion of One-Month Postoperative Patient Results\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta –\n \n\n TheNewswire -\n \n\n October 14, 2025\n \n\n -\nOcumetics Technology Corp\n \n\n .\n \n\n (“Ocumetics” or the “Company”)\n(TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in advanced\nophthalmic technology, is pleased to announce that it is holding a\nwebinar to discuss the one-month patient results for its initial Group\n1 patients that received the Ocumetics Accommodating Intraocular Lens\n(the “Ocumetics Lens”).\n \n\n\n\n Webinar details are as follows:\n \n\n\n\n\n Date:\n \n\n\n Thursday, October 15,\n2025\n \n\n\n\n\n Time:\n \n\n\n 6:00 PM ET\n \n\n\n\n Join Ocumetics Director and CEO, Dean Burns, for an\nexclusive webinar covering important updates on our first-in-human\n(“FIH”) study and what lies ahead.\n \n\n\n\n Topics will include:\n \n\n\n\n 1. Discussion of one-month postoperative patient\nresults and observations from the FIH study\n \n\n\n\n 2. Next steps to complete the Ocumetics FIH\nstudy\n \n\n\n\n 3. Live Q&A session with Dean Burns\n \n\n\n\n This is a timely opportunity to gain insight into\nOcumetics’ progress at this critical stage of development.\n \n\n\n\n Reserve your spot now at\n \n\n\n\n www.ocumetics.com/webinar\n \n\n\n\n .\n \n\n\n\n About Ocumetics\n \n\n\n\n Ocumetics Technology Corp.\n \n\n (\n \n\n TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO)\nis a Canadian research and product development company that is\ndedicated to developing advanced vision correction solutions that\nenhance the quality of life for patients.  Through innovative\nresearch and development, Ocumetics aims to transform the field of\nophthalmology with state-of-the-art intraocular lenses and other\nvision-enhancing technologies.\n \n\n\n\n Ocumetics is in the first-in-human early feasibility\nstudy phase of a game-changing technology for the ophthalmic industry.\n Ocumetics has developed an intraocular lens that fits within the\nnatural lens compartment of the eye, potentially to eliminate the need\nfor corrective lenses.  It is designed to allow the eye’s natural\nmuscle activity to shift focus from distance to near, providing clear\nvision at all distances ...